Search
-
News
As 2019 comes to an end, take a moment to reflect on the science stories that made the year one to remember.
… Monday, December 16, 2019 Many medical breakthroughs blossom from the seeds of basic science research. This past year, Memorial Sloan Kettering scientists made fundamental discoveries in several basic science fields, including cell biology, molecular biology, developmental biology, and more. Much of
-
News
The Gerstner Sloan Kettering Graduate School of Biomedical Sciences welcomed 16 students to our annual Summer Undergraduate Research Program.
… Tuesday, June 14, 2016 Sixteen undergraduate students arrived on June 6, 2016, to begin their Summer Undergraduate Research Program (SURP) under the auspices of the Gerstner Sloan Kettering Graduate School of Biomedical Sciences. They were greeted by GSK Associate Dean Linda Burnley and SURP faculty
-
News
Rather than promoting genetic chaos, loss of p53 leads to an orderly progression of genetic changes that no one saw coming.
… Wednesday, August 17, 2022 More than half of all cancers have mutations in a gene called p53 . The protein made from this gene is what’s called a tumor suppressor: When working properly, it guards against cancer development — in part, by detecting damaged DNA and alerting cells to repair it. Cells without
-
News
Recent advances in technology allow Memorial Sloan Kettering Cancer Center pathologists to perform swift and accurate molecular analyses of tumor cells in patients with colorectal cancer. By determining the gene mutations of individual tumors, doctors are able to prescribe treatments that are most likely to be effective for patients, while avoiding drugs that will provide no benefit and may cause serious side effects.
… Friday, October 1, 2010 Recent advances in technology allow Memorial Sloan Kettering Cancer Center pathologists to perform swift and accurate molecular analyses of tumor cells in patients with colorectal cancer. By determining the gene mutations of individual tumors, doctors may be able to prescribe
-
News
Gregory Mazo has been awarded the Chairman’s Prize for his first-author paper Spatial Control of Primary Ciliogenesis by Subdistal Appendages Alters Sensation-Associated Properties of Cilia, published in Developmental Cell in 2016.
… Tuesday, August 29, 2017 Gregory Mazo has been awarded the Chairman’s Prize for his first-author paper Spatial Control of Primary Ciliogenesis by Subdistal Appendages Alters Sensation-Associated Properties of Cilia , published in Developmental Cell in 2016. Greg, who successfully defended his dissertation
-
News
The recent marketing of "at home" genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH, Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center (MSKCC).
… Tuesday, March 18, 2008 The recent marketing of “at home” genomic tests for disease risk may be premature, according to Dr. Kenneth Offit, MD, MPH , Chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center (MSKCC). “Health professionals are now faced with the prospect of their
-
News
Meet Dr. Monique James, who is part of MSK’s Department of Psychiatry and Behavioral Sciences. Her journey with MSK started 18 years ago before she even started medical school.
… Tuesday, January 21, 2025 In 2017, Monique James, MD joined the Department of Psychiatry and Behavioral Sciences at Memorial Sloan Kettering Cancer Center (MSK), but her journey with MSK started 18 years before she even started medical school. “I worked as a session assistant — when they were called
-
News
Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.
… Monday, December 3, 2018 The American Society of Hematology (ASH) annual meeting is the world’s premier event devoted to the study of blood cancers and disorders. More than 25,000 people are attending the 2018 assembly, held December 1 through 4 in San Diego. Memorial Sloan Kettering researchers at the
-
News
A rare form of stomach cancer caused by an inherited gene mutation can be avoided by having the stomach removed — and many people can adjust to life afterward.
… Wednesday, November 16, 2016 Summary People with an inherited mutation in the CDH1 gene are at a very high risk of developing a rare type of stomach cancer . Having the stomach removed, which can be performed using minimally invasive methods, can eliminate this risk. Most people recover well from the
-
MSK News
Craig B. Thompson, Lisa DeAngelis, and Joan Massagué write that as we mark the 50th year of the War on Cancer and look to the future, our mission at Memorial Sloan Kettering is nothing less than conquering the most urgent challenge: preventing cancer’s spread.
… Thursday, July 1, 2021 Dear MSK Community, These are the four most frightening words for a patient to hear: “Your cancer is back.” As we mark the 50th year of the War on Cancer and look to the future, our mission at Memorial Sloan Kettering is nothing less than conquering the most urgent challenge: preventing